Pharmaceuticals

The Pharmaceutical Drug Delivery Market Is Evolving Due To Increasing Prevalence Of Skin Conditions Fueling The Growth Of The Due To Rising Pollution And Skin Sensitivity

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Pharmaceutical Drug Delivery Market Between 2026 And 2030?

The pharmaceutical drug delivery market has witnessed robust expansion in recent years. Its valuation is anticipated to climb from $1883.27 billion in 2025 to $2007.97 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.6%. This historical development can be ascribed to factors such as the increasing incidence of chronic diseases, breakthroughs in pharmaceutical formulations, the development of hospital infrastructure, an expanding elderly population, and the wider uptake of oral and injectable drug administration approaches.

The size of the pharmaceutical drug delivery market is anticipated to experience substantial expansion over the coming years. By 2030, this market is projected to reach $2612.78 billion, exhibiting a compound annual growth rate (CAGR) of 6.8%. Several factors are expected to drive this growth during the forecast period, including the rise of biologics and biosimilars, the incorporation of digital monitoring devices, advancements in nanocarrier systems, the expansion of home care and remote treatment options, and a heightened need for patient-focused therapies. Key trends anticipated during the forecast period encompass targeted drug delivery systems, formulations utilizing nanotechnology, wearable devices for drug delivery, personalized medicine approaches, and methods for minimally invasive delivery.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6962&type=smp

Which Important Drivers Are Guiding The Pharmaceutical Drug Delivery Market Growth?

The expansion of the pharmaceutical drug delivery market is anticipated to be fueled by the increasing occurrence of chronic diseases. Chronic disease prevalence refers to the total existing cases within a population at any given point. Pharmaceutical drug delivery aids patients with chronic conditions by administering medicines precisely to target specific body areas for treatment. For example, global data from September 2023, released by the World Health Organization, a Switzerland-based specialized agency of the United Nations, indicated that non-communicable or chronic diseases were responsible for 41 million deaths annually, constituting 74% of total fatalities. Specifically, cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million, chronic respiratory diseases for 4.1 million, and diabetes for 2.0 million. Consequently, the rising incidence of chronic diseases is a significant impetus for the growth of the pharmaceutical drug delivery market.

Which Segment Categories Are Included In The Pharmaceutical Drug Delivery Market Segment Analysis?

The pharmaceutical drug delivery market covered in this report is segmented –

1) By Route Of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes

2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications

3) By End-User: Hospitals, Home Care Settings, ASC Or Clinics, Other End Users

Subsegments:

1) By Oral: Tablets, Capsules, Liquids, Powders

2) By Ocular: Eye Drops, Ocular Inserts, Ocular Implants

3) By Pulmonary: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

4) By Nasal: Nasal Sprays, Nasal Gels, Nasal Powders

5) By Injectable: Intravenous (IV) Injections, Intramuscular (IM) Injections, Subcutaneous (SC) Injections, Biologics And Biosimilars

6) By Topical: Creams, Ointments, Gels, Transdermal Patches

7) By Other Routes: Sublingual, Buccal, Rectal, Intranasal

What Trends Are Influencing The Evolution Of The Pharmaceutical Drug Delivery Market?

Leading companies within the pharmaceutical drug delivery market are increasingly adopting a strategic partnership approach, aiming to discover innovative transport targets and shuttle molecules to enhance medicine delivery to the brain. Such strategic alliances entail companies utilizing each other’s strengths and resources to achieve mutual benefits and success. For example, in September 2023, Cordance Medical, a US-based medical equipment manufacturer company, established a strategic partnership with EXACT Therapeutics to simplify drug delivery to the brain. This collaboration unites Cordance Medical’s NeuroAccess platform, which can non-surgically open the blood-brain barrier (BBB), with EXACT Therapeutics’ Acoustic Cluster Therapy (ACT) technology. The goal of this partnership is to improve treatments for brain diseases, including tumors and neurodegenerative disorders, by making it easier for medicines to reach their target in the brain. EXACT Therapeutics is a UK-based, clinical-stage biopharmaceutical company.

Who Are The Active Companies Shaping The Pharmaceutical Drug Delivery Market?

Major companies operating in the pharmaceutical drug delivery market are 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG

Get The Full Pharmaceutical Drug Delivery Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Which Region Represents The Largest Share Of The Pharmaceutical Drug Delivery Market?

North America was the largest region in the pharmaceutical drug delivery market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceutical Drug Delivery Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Browse Through More Reports Similar to the Global Pharmaceutical Drug Delivery Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795